Peter Jüni

Researcher Next ID · RN-030041

Researcher · Medicine

Institute of Social and Preventive Medicine

Lausanne, Switzerland

Not currently recruitingFunding unknown

Works count: 918
Citation count: 302,995
H-index: 167
i10-index: 576

Research interests

Medicine

Coronary Interventions and Diagnostics

Acute Myocardial Infarction Research

Antiplatelet Therapy and Cardiovascular Diseases

Cardiac Imaging and Diagnostics

Cardiac Valve Diseases and Treatments

Publications

2023 ESC Guidelines for the management of acute coronary syndromes
European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad191
2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Revista Española de Cardiología (English Edition) · 2022 · 10.1016/j.rec.2022.05.006
2021 ESC/EACTS Guidelines for the management of valvular heart disease
European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab395
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2108749
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
JAMA · 2020 · https://doi.org/10.1001/jama.2020.17023
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
European Heart Journal · 2020 · https://doi.org/10.1093/eurheartj/ehaa575
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
European Heart Journal · 2019 · 10.1093/eurheartj/ehz486
RoB 2: a revised tool for assessing risk of bias in randomised trials
BMJ · 2019 · https://doi.org/10.1136/bmj.l4898
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial
The Lancet · 2019 · 10.1016/s0140-6736(19)31997-x
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz455
2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)
European Heart Journal · 2019 · 10.1093/eurheartj/ehz467
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Atherosclerosis · 2019 · 10.1016/j.atherosclerosis.2019.08.014
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
European Heart Journal · 2018 · 10.1093/eurheartj/ehy340
2018 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy394
2018 ESC Guidelines for the diagnosis and management of syncope
European Heart Journal · 2018 · 10.1093/eurheartj/ehy037
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
The Lancet · 2018 · 10.1016/s0140-6736(18)31858-0
The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability
European Heart Journal · 2018 · 10.1093/eurheartj/ehy267
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve
New England Journal of Medicine · 2018 · 10.1056/nejmoa1803538
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
European Heart Journal · 2017 · 10.1093/eurheartj/ehx095
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
European Heart Journal · 2017 · 10.1093/eurheartj/ehx419
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
European Heart Journal · 2017 · 10.1093/eurheartj/ehx419
2017 ESC/EACTS Guidelines for the management of valvular heart disease
European Heart Journal · 2017 · 10.1093/eurheartj/ehx391
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
European Heart Journal · 2017 · 10.1093/eurheartj/ehx419
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
BMJ · 2016 · https://doi.org/10.1136/bmj.i4919
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
European Heart Journal · 2016 · 10.1093/eurheartj/ehw148
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
The Lancet · 2015 · 10.1016/s0140-6736(15)60292-6
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
European Heart Journal · 2014 · 10.1093/eurheartj/ehu282
Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease
New England Journal of Medicine · 2014 · 10.1056/nejmoa1408758
2014 ESC/EACTS Guidelines on myocardial revascularization
European Journal of Cardio-Thoracic Surgery · 2014 · 10.1093/ejcts/ezu366
Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials
Annals of Internal Medicine · 2012 · 10.7326/0003-4819-157-6-201209180-00537
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
European Heart Journal · 2012 · 10.1093/eurheartj/ehs215
Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease
New England Journal of Medicine · 2012 · 10.1056/nejmoa1205361
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
BMJ · 2011 · https://doi.org/10.1136/bmj.d5928
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
BMJ · 2008 · 10.1136/bmj.39465.451748.ad
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
The Lancet · 2007 · 10.1016/s0140-6736(07)61444-5
Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization
New England Journal of Medicine · 2005 · 10.1056/nejmoa051175
Assessing the quality of controlled clinical trials
BMJ · 2001 · 10.1136/bmj.323.7303.42
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
JAMA · 1999 · 10.1001/jama.282.11.1054
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews
The Lancet · 1996 · 10.1016/s0140-6736(96)90538-3

Current projects

No projects listed.